Vanda Pharmaceuticals (VNDA) – Hot FDA News
-
Vanda Pharmaceuticals (VNDA) Announces FDA Update for supplemental NDA for HETLIOZ in the Treatment of Insomnia
-
Vanda Pharmaceuticals (VNDA) Phase III Study of Tradipitant in Gastroparesis Did Not Meet Primary Endpoint
-
-
-
-
-
-
Back to VNDA Stock Lookup